Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Development and application of a simple assay to quantify cellular adducts of platinum complexes with DNA.

× No keyword cloud information.

12 in total

1. Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody.

Authors: M J Tilby; C Johnson; R J Knox; J Cordell; J J Roberts; C J Dean
Journal: Cancer Res Date: 1991-01-01 Impact factor: 12.701

2. Platinum-DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometry.

Authors: R J Parker; I Gill; R Tarone; J A Vionnet; S Grunberg; F M Muggia; E Reed
Journal: Carcinogenesis Date: 1991-07 Impact factor: 4.944

Review 3. Cisplatin and derived anticancer drugs: mechanism and current status of DNA binding.

Authors: M J Bloemink; J Reedijk
Journal: Met Ions Biol Syst Date: 1996

Review 4. Comparative clinical pharmacology of cisplatin and carboplatin.

Authors: D J Murry
Journal: Pharmacotherapy Date: 1997 Sep-Oct Impact factor: 4.705

5. Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy.

Authors: E Reed; R F Ozols; R Tarone; S H Yuspa; M C Poirier
Journal: Proc Natl Acad Sci U S A Date: 1987-07 Impact factor: 11.205

6. In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells.

Authors: C P Saris; P J van de Vaart; R C Rietbroek; F A Blommaert
Journal: Carcinogenesis Date: 1996-12 Impact factor: 4.944

7. The formation and persistence of carboplatin-DNA adducts in rats.

Authors: F A Blommaert; C Michael; H C van Dijk-Knijnenburg; J H Schornagel; L den Engelse; A M Fichtinger-Schepman
Journal: Cancer Chemother Pharmacol Date: 1996 Impact factor: 3.333

8. A comparison of in vitro platinum-DNA adduct formation between carboplatin and cisplatin.

Authors: A Hongo; S Seki; K Akiyama; T Kudo
Journal: Int J Biochem Date: 1994-08

9. Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy.

Authors: E Reed; S H Yuspa; L A Zwelling; R F Ozols; M C Poirier
Journal: J Clin Invest Date: 1986-02 Impact factor: 14.808

Development and application of a simple assay to quantify cellular adducts of platinum complexes with DNA.

1. Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody.

2. Platinum-DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometry.

Review 3. Cisplatin and derived anticancer drugs: mechanism and current status of DNA binding.

Review 4. Comparative clinical pharmacology of cisplatin and carboplatin.

5. Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy.

6. In vitro formation of DNA adducts by cisplatin, lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells.

7. The formation and persistence of carboplatin-DNA adducts in rats.

8. A comparison of in vitro platinum-DNA adduct formation between carboplatin and cisplatin.

9. Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy.

Review 10. The current status of new platinum analogs.

Review 1. Unusual DNA binding modes for metal anticancer complexes.

Review 2. Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer.

3. Oxaliplatin-DNA adduct formation in white blood cells of cancer patients.